Home › Funds › Geode Capital Management › BBNX
Geode Capital Management position in BBNX
BETA BIONICS INC · Health Care
Latest position (Q2 2026)1.07M sh
Reported value held$16.82M
Portfolio Weight0.00%
First reportedQ1 2025
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 306.02K | $3.75M | New |
| Q2 2025 | 312.93K | $4.56M | Add |
| Q3 2025 | 917.55K | $18.24M | Add |
| Q4 2025 | 921.46K | $28.08M | Hold |
| Q1 2026 | 932.68K | $9.35M | Add |
| Q2 2026 | 1.07M | $16.82M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BBNX
- Vanguard Group 2.22M sh · $67.59M · Q4 2025
- Morgan Stanley 4.27M sh · $66.86M · Q2 2026
- BlackRock Inc 3.34M sh · $52.34M · Q2 2026
- Point72 Asset Management 2.25M sh · $35.33M · Q2 2026
- Millennium Management 956.24K sh · $14.98M · Q2 2026
- Balyasny Asset Management 855.68K sh · $13.41M · Q2 2026
- JPMorgan Chase & Co 703.36K sh · $11.96M · Q2 2026
- Farallon Capital Management 595.00K sh · $9.32M · Q2 2026
- Bank of America Corp 546.65K sh · $8.57M · Q2 2026
- Goldman Sachs Group 537.11K sh · $8.42M · Q2 2026
- UBS Group AG 386.62K sh · $6.06M · Q2 2026